Featured Publications
Comparison of Sex-Based In-Hospital Procedural Outcomes and Hospital Readmission Frequency After Patent Foramen Ovale Occluder Device Placement: A Propensity Matched National Cohort
Fakhra S, Sattar Y, Patel N, Aziz S, Titus A, Almas T, Aamir M, Sulaiman S, Mishra N, Elgendy I, Raina S, Jagadeesan V, Daggubati R, Alraies M. Comparison of Sex-Based In-Hospital Procedural Outcomes and Hospital Readmission Frequency After Patent Foramen Ovale Occluder Device Placement: A Propensity Matched National Cohort. Current Problems In Cardiology 2023, 48: 101662. PMID: 36868331, DOI: 10.1016/j.cpcardiol.2023.101662.Peer-Reviewed Original ResearchConceptsAcute kidney injuryAcute ischemic strokeNationwide Readmissions DatabaseMultivariate odds ratiosDevice placementAKI incidenceHospital mortalityCardiac tamponadeIschemic strokeHigher total hospitalization costsNational retrospective cohort studySecondary cardiovascular outcomesRetrospective cohort studyTotal hospitalization costsComparison of sexAKI occurrenceNephrotoxic medicationsReadmission LOSRecurrent strokeCardiovascular outcomesIndex hospitalizationKidney injuryPostprocedural bleedingCohort studyComplication rate
2018
Sex-Specific Outcomes After Transcatheter Aortic Valve Replacement: FDA Patient-Level Meta-Analysis of Premarket Clinical Trials
Zusterzeel R, Mishra NK, Beydoun H, Laschinger J, Wu C, Dong LM, Lin JA, Marinac-Dabic D, Strauss DG, Caños DA. Sex-Specific Outcomes After Transcatheter Aortic Valve Replacement: FDA Patient-Level Meta-Analysis of Premarket Clinical Trials. Journal Of Women's Health 2018, 27: 808-814. PMID: 29741978, DOI: 10.1089/jwh.2017.6760.Peer-Reviewed Original ResearchConceptsTranscatheter aortic valve replacementAortic valve replacementClinical trialsPatient-level dataPremarket clinical trialsLower riskMajor bleedingKidney injuryIschemic strokeValve replacementPacemaker implantationMortality riskDichotomous outcomesEfficacy of TAVRInvasive alternative approachPatient-Level MetaLong-term outcomesSex-specific outcomesLower mortality riskRandom-effects modelReintervention riskTAVR armIndividual comorbiditiesPostprocedural complicationsAcute outcomes